Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of multiple subcutaneous injections of ABT-981 in patients with osteoarthritis of the kn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• ABT-981 (ABT-981)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED